Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids

Therapy of patients with pemphigus vulgaris with systemic corticosteroids may not be effective enough or lead to the development of severe adverse events that make it necessary to reduce the dose of corticosteroid. In such cases, it is possible to use the immunosuppressants. The literature review an...

Full description

Saved in:
Bibliographic Details
Main Authors: Vadim V. Chikin, Arfenya E. Karamova
Format: Article
Language:English
Published: State Scientific Center of Dermatovenereology and Cosmetology 2024-12-01
Series:Vestnik Dermatologii i Venerologii
Subjects:
Online Access:https://vestnikdv.ru/jour/article/viewFile/16808/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832088154874576896
author Vadim V. Chikin
Arfenya E. Karamova
author_facet Vadim V. Chikin
Arfenya E. Karamova
author_sort Vadim V. Chikin
collection DOAJ
description Therapy of patients with pemphigus vulgaris with systemic corticosteroids may not be effective enough or lead to the development of severe adverse events that make it necessary to reduce the dose of corticosteroid. In such cases, it is possible to use the immunosuppressants. The literature review analyzes case reports and the results of studies that evaluated the effectiveness and safety of drugs used for immunosuppressive therapy of patients with pemphigus vulgaris. The drugs doses, the studies design, and criteria for evaluating the effectiveness of therapy in patients with pemphigus are considered. As a result of the analysis, it was shown that case reports and non-compatarive studies demonstrate the effectiveness and steroid-sparing effect of azathioprine, dapsone, methotrexate, mycophenolate mofetil, cyclosporine and cyclophosphamide in the treatment of patients with pemphigus vulgaris. Nevertheless, comparative studies show an increase in the effectiveness of therapy in patients with pemphigus and a faster achievement of therapeutic effect when prescribing cyclophosphamide, but not azathioprine, dapsone, methotrexate, mycophenolate mofetil or cyclosporine. However, the toxicity of cyclophosphamide limits its use in pemphigus. Thus, adjuvant drugs can be used in the treatment of patients with pemphigus in situations where it is not possible to reduce the dose of a systemic corticosteroid, especially in cases of severe adverse events of corticosteroid therapy.
format Article
id doaj-art-191deec9388f492f9cdffe2f172b98eb
institution Kabale University
issn 0042-4609
2313-6294
language English
publishDate 2024-12-01
publisher State Scientific Center of Dermatovenereology and Cosmetology
record_format Article
series Vestnik Dermatologii i Venerologii
spelling doaj-art-191deec9388f492f9cdffe2f172b98eb2025-02-05T20:41:43ZengState Scientific Center of Dermatovenereology and CosmetologyVestnik Dermatologii i Venerologii0042-46092313-62942024-12-01100662110.25208/vdv168081308Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroidsVadim V. Chikin0https://orcid.org/0000-0002-9688-2727Arfenya E. Karamova1https://orcid.org/0000-0003-3805-8489State Research Center of Dermatovenereology and CosmetologyState Research Center of Dermatovenereology and CosmetologyTherapy of patients with pemphigus vulgaris with systemic corticosteroids may not be effective enough or lead to the development of severe adverse events that make it necessary to reduce the dose of corticosteroid. In such cases, it is possible to use the immunosuppressants. The literature review analyzes case reports and the results of studies that evaluated the effectiveness and safety of drugs used for immunosuppressive therapy of patients with pemphigus vulgaris. The drugs doses, the studies design, and criteria for evaluating the effectiveness of therapy in patients with pemphigus are considered. As a result of the analysis, it was shown that case reports and non-compatarive studies demonstrate the effectiveness and steroid-sparing effect of azathioprine, dapsone, methotrexate, mycophenolate mofetil, cyclosporine and cyclophosphamide in the treatment of patients with pemphigus vulgaris. Nevertheless, comparative studies show an increase in the effectiveness of therapy in patients with pemphigus and a faster achievement of therapeutic effect when prescribing cyclophosphamide, but not azathioprine, dapsone, methotrexate, mycophenolate mofetil or cyclosporine. However, the toxicity of cyclophosphamide limits its use in pemphigus. Thus, adjuvant drugs can be used in the treatment of patients with pemphigus in situations where it is not possible to reduce the dose of a systemic corticosteroid, especially in cases of severe adverse events of corticosteroid therapy.https://vestnikdv.ru/jour/article/viewFile/16808/pdfpemphigus vulgarisineffectiveness of corticosteroidsimmunosuppressants
spellingShingle Vadim V. Chikin
Arfenya E. Karamova
Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
Vestnik Dermatologii i Venerologii
pemphigus vulgaris
ineffectiveness of corticosteroids
immunosuppressants
title Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
title_full Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
title_fullStr Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
title_full_unstemmed Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
title_short Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
title_sort immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
topic pemphigus vulgaris
ineffectiveness of corticosteroids
immunosuppressants
url https://vestnikdv.ru/jour/article/viewFile/16808/pdf
work_keys_str_mv AT vadimvchikin immunosuppressivetherapyofpatientswithpemphiguswithineffectivenessofsystemiccorticosteroids
AT arfenyaekaramova immunosuppressivetherapyofpatientswithpemphiguswithineffectivenessofsystemiccorticosteroids